Travere Therapeutics Price Target Raised to $23.00/Share From $18.00 by Canaccord Genuity
Travere Therapeutics Price Target Raised to $23.00/Share From $18.00 by Canaccord Genuity
Travere Therapeutics的股票目标价格从18.00美元上调至23.00美元，由Canaccord Genuity给出。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间